1. Home
  2. BIAF vs AIHS Comparison

BIAF vs AIHS Comparison

Compare BIAF & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • AIHS
  • Stock Information
  • Founded
  • BIAF 2014
  • AIHS 2014
  • Country
  • BIAF United States
  • AIHS China
  • Employees
  • BIAF N/A
  • AIHS N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • AIHS Finance: Consumer Services
  • Sector
  • BIAF Health Care
  • AIHS Finance
  • Exchange
  • BIAF Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • BIAF 12.2M
  • AIHS 11.9M
  • IPO Year
  • BIAF 2022
  • AIHS 2018
  • Fundamental
  • Price
  • BIAF $0.30
  • AIHS $0.32
  • Analyst Decision
  • BIAF Hold
  • AIHS
  • Analyst Count
  • BIAF 1
  • AIHS 0
  • Target Price
  • BIAF N/A
  • AIHS N/A
  • AVG Volume (30 Days)
  • BIAF 11.2M
  • AIHS 4.2M
  • Earning Date
  • BIAF 08-13-2025
  • AIHS 08-13-2025
  • Dividend Yield
  • BIAF N/A
  • AIHS N/A
  • EPS Growth
  • BIAF N/A
  • AIHS N/A
  • EPS
  • BIAF N/A
  • AIHS N/A
  • Revenue
  • BIAF $8,809,228.00
  • AIHS $5,878,700.00
  • Revenue This Year
  • BIAF N/A
  • AIHS N/A
  • Revenue Next Year
  • BIAF $20.00
  • AIHS N/A
  • P/E Ratio
  • BIAF N/A
  • AIHS N/A
  • Revenue Growth
  • BIAF 78.40
  • AIHS 12.21
  • 52 Week Low
  • BIAF $0.16
  • AIHS $0.26
  • 52 Week High
  • BIAF $2.99
  • AIHS $1.70
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 50.96
  • AIHS 30.64
  • Support Level
  • BIAF $0.22
  • AIHS $0.29
  • Resistance Level
  • BIAF $0.46
  • AIHS $0.35
  • Average True Range (ATR)
  • BIAF 0.04
  • AIHS 0.16
  • MACD
  • BIAF 0.01
  • AIHS -0.06
  • Stochastic Oscillator
  • BIAF 30.51
  • AIHS 3.70

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.

Share on Social Networks: